Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01037790

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:16.725852+00:00

Published At

2021-03-11T00:00:00+00:00

Record Updated At

2021-03-11

Results Posted At

2021-03-11

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Adult Solid Tumor", "Adenocarcinoma of the Colon", "Adenocarcinoma of the Rectum", "Adult Central Nervous System Germ Cell Tumor", "Adult Teratoma", "Benign Teratoma", "Estrogen Receptor-negative Breast Cancer", "Estrogen Receptor-positive Breast Cancer", "Familial Testicular Germ Cell Tumor", "HER2-negative Breast Cancer", "HER2-positive Breast Cancer", "Male Breast Cancer", "Ovarian Immature Teratoma", "Ovarian Mature Teratoma", "Ovarian Monodermal and Highly Specialized Teratoma", "Progesterone Receptor-negative Breast Cancer", "Progesterone Receptor-positive Breast Cancer", "Recurrent Breast Cancer", "Recurrent Colon Cancer", "Recurrent Extragonadal Germ Cell Tumor", "Recurrent Extragonadal Non-seminomatous Germ Cell Tumor", "Recurrent Extragonadal Seminoma", "Recurrent Malignant Testicular Germ Cell Tumor", "Recurrent Melanoma", "Recurrent Ovarian Germ Cell Tumor", "Recurrent Rectal Cancer", "Stage III Extragonadal Non-seminomatous Germ Cell Tumor", "Stage III Extragonadal Seminoma", "Stage III Malignant Testicular Germ Cell Tumor", "Stage III Ovarian Germ Cell Tumor", "Stage IV Breast Cancer", "Stage IV Colon Cancer", "Stage IV Extragonadal Non-seminomatous Germ Cell Tumor", "Stage IV Extragonadal Seminoma", "Stage IV Melanoma", "Stage IV Ovarian Germ Cell Tumor", "Stage IV Rectal Cancer", "Testicular Immature Teratoma", "Testicular Mature Teratoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2021-03-11"

protocolSection.identificationModule.nctId

"NCT01037790"

protocolSection.identificationModule.officialTitle

"Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2021-03-11"

Study condition terms

• Adult Solid Tumor (protocolSection.conditionsModule.conditions)
• Adenocarcinoma of the Colon (protocolSection.conditionsModule.conditions)
• Adenocarcinoma of the Rectum (protocolSection.conditionsModule.conditions)
• Adult Central Nervous System Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Adult Teratoma (protocolSection.conditionsModule.conditions)
• Benign Teratoma (protocolSection.conditionsModule.conditions)
• Estrogen Receptor-negative Breast Cancer (protocolSection.conditionsModule.conditions)
• Estrogen Receptor-positive Breast Cancer (protocolSection.conditionsModule.conditions)
• Familial Testicular Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• HER2-negative Breast Cancer (protocolSection.conditionsModule.conditions)
• HER2-positive Breast Cancer (protocolSection.conditionsModule.conditions)
• Male Breast Cancer (protocolSection.conditionsModule.conditions)
• Ovarian Immature Teratoma (protocolSection.conditionsModule.conditions)
• Ovarian Mature Teratoma (protocolSection.conditionsModule.conditions)
• Ovarian Monodermal and Highly Specialized Teratoma (protocolSection.conditionsModule.conditions)
• Progesterone Receptor-negative Breast Cancer (protocolSection.conditionsModule.conditions)
• Progesterone Receptor-positive Breast Cancer (protocolSection.conditionsModule.conditions)
• Recurrent Breast Cancer (protocolSection.conditionsModule.conditions)
• Recurrent Colon Cancer (protocolSection.conditionsModule.conditions)
• Recurrent Extragonadal Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Recurrent Extragonadal Non-seminomatous Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Recurrent Extragonadal Seminoma (protocolSection.conditionsModule.conditions)
• Recurrent Malignant Testicular Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Recurrent Melanoma (protocolSection.conditionsModule.conditions)
• Recurrent Ovarian Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Recurrent Rectal Cancer (protocolSection.conditionsModule.conditions)
• Stage III Extragonadal Non-seminomatous Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Stage III Extragonadal Seminoma (protocolSection.conditionsModule.conditions)
• Stage III Malignant Testicular Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Stage III Ovarian Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Stage IV Breast Cancer (protocolSection.conditionsModule.conditions)
• Stage IV Colon Cancer (protocolSection.conditionsModule.conditions)
• Stage IV Extragonadal Non-seminomatous Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Stage IV Extragonadal Seminoma (protocolSection.conditionsModule.conditions)
• Stage IV Melanoma (protocolSection.conditionsModule.conditions)
• Stage IV Ovarian Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Stage IV Rectal Cancer (protocolSection.conditionsModule.conditions)
• Testicular Immature Teratoma (protocolSection.conditionsModule.conditions)
• Testicular Mature Teratoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.